NCT03036891 - Naloxegol for Opioid-Related Gastroparesis | Biotech Hunter

Timeline

Start Date

December 29, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions

GastroparesisOpioid Use

Interventions

DRUG

Naloxegol 25 MG Oral Tablet [Movantik]

Patients will be given the study drug (Movantik 25 mg).They will take this daily in the morning 1 hour before breakfast for four weeks.

DRUG

Placebo Oral Tablet

Patients will be given Placebo (Placebo 25 mg).They will take this daily in the morning 1 hour before breakfast for four weeks.

Trial Locations (1)

Lewis Katz School of Medicine at Temple University, Philadelphia